by Collectif | 14 Sep, 2014 | Bioethics press synthesis | MAP – Surrogacy
Medicines used in in-vitro fertilisation (IVF) cycles are being sold illegally on e-bay, for a third of the normal price. In Great Britain, many women who cannot conceive and who cannot afford the cost of this ovary-stimulating medication are choosing to obtain the...
by Collectif | 14 Sep, 2014 | Bioethics press synthesis | MAP – Surrogacy
In a decree announced on Thursday, 11 September, the European Court of Human Rights (ECHR) declared that “State authorities can legitimately carry out ‘legal checks’ before authorising the entry of a baby born as a result of surrogacy arrangements...
by Collectif | 14 Sep, 2014 | Bioethics press synthesis | Abortion - Medical termination of Pregnancy(MTP)
Last May, the Spanish Justice Minister, Alberto Ruiz-Gallardon, who created the draft bill aimed at limiting the number of abortions, announced that the bill could be approved by both assemblies before the summer (Gènéthique press review on May 9th, 2014). At the end...
by Collectif | 11 Sep, 2014 | Bioethics press synthesis | All other themes
Male contraception could soon be available to the general public. The name of this type of contraception? Vasalgel, “a gel that is injected into the vas deferens and prevents sperm from being ejaculated”. This product has been developed by the Parsemus...
by Collectif | 11 Sep, 2014 | Bioethics press synthesis | Embryo research and alternatives
On 10 September, the scientific journal, Nature, revealed that a team of Japanese scientists would soon be attempting to treat a patient suffering from age-related macular degeneration (ARMD) with iPS cells (Gènéthique press review on September 11th, 2014). ...